(Q45335472)

13 December 2017

title

Time required for navigated macular laser photocoagulation treatment with the Navilas (English)

1 reference

13 December 2017

1 reference

1

1 reference

13 December 2017

Marcus Kernt

2

1 reference

13 December 2017

Marco A Cortes

series ordinal

3

1 reference

13 December 2017

Igor Kozak

series ordinal

4

1 reference

13 December 2017

language of work or name

1 reference

7 August 2012

1 reference

Graefe's Archive for Clinical and Experimental Ophthalmology

13 December 2017

published in

1 reference

13 December 2017

volume

251

1 reference

13 December 2017

issue

4

1 reference

13 December 2017

page(s)

1049-1053

1 reference

https://scigraph.springernature.com/pub.10.1007/s00417-012-2119-0

13 December 2017

exact match

0 references

cites work

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal [...]

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2119-0

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2119-0

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2119-0

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2119-0

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2119-0

Does laser still have a role in the management of retinal vascular and neovascular diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2119-0

Semiautomated patterned scanning laser for retinal photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2119-0

Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2119-0

Focal navigated laser photocoagulation in retinovascular disease: clinical results in initial case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2119-0

Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema

21 January 2018

1 reference

12 December 2020

Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema

1 reference

12 December 2020

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group

1 reference

12 December 2020

Focal and panretinal photocoagulation with a navigated laser (NAVILAS®)

1 reference

12 December 2020

Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group

1 reference

12 December 2020

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein

1 reference

12 December 2020

Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial

1 reference

12 December 2020

10.1007/S00417-012-2119-0

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1051728430

0 references

1 reference